Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody―Associated VasculitisWALSH, Michael; FLOSSMANN, Oliver; BERDEN, Annelies et al.Arthritis and rheumatism. 2012, Vol 64, Num 2, pp 542-548, issn 0004-3591, 7 p.Article

EULAR recommendations for the management of primary small and medium vessel vasculitisMUKHTYAR, C; GUILLEVIN, L; MERKEL, P. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 310-317, issn 0003-4967, 8 p.Article

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trialsSUPPIAH, Ravi; HADDEN, Robert D. M; BATRA, Rajbir et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 12, pp 2214-2222, issn 1462-0324, 9 p.Article

Long-term patient survival in ANCA-associated vasculitisFLOSSMANN, Oliver; BERDEN, Annelies; MUKHTYAR, Chetan et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 3, pp 488-494, issn 0003-4967, 7 p.Article

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitisDE GROOT, Kirsten; RASMUSSEN, Niels; BACON, Paul A et al.Arthritis and rheumatism. 2005, Vol 52, Num 8, pp 2461-2469, issn 0004-3591, 9 p.Article

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trialsHEIJL, C; HARPER, L; FLOSSMANN, O et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 8, pp 1415-1421, issn 0003-4967, 7 p.Article

Rituximab versus Cyclophosphamide in ANCA-Associated Renal VasculitisJONES, Rachel B; COHEN TERVAERT, Jan Willem; WALSH, Dorothy et al.The New England journal of medicine. 2010, Vol 363, Num 3, pp 211-220, issn 0028-4793, 10 p.Article

EULAR recommendations for the management of large vessel vasculitisMUKHTYAR, C; GUILLEVIN, L; MERKEL, P. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 318-323, issn 0003-4967, 6 p.Article

EULAR recommendations for conducting clinical studies and/ or clinical trials in systemic vasculitis : focus on anti-neutrophil cytoplasm antibody-associated vasculitisH, Bernhard; FLOSSMANN, Oliver; SCOTT, David G. I et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 5, pp 605-617, issn 0003-4967, 13 p.Article

Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritisDE LIND VAN WIJNGAARDEN, Robert A. F; HAUER, Herbert A; BAJEMA, Ingeborg M et al.Journal of the American Society of Nephrology. 2007, Vol 18, Num 7, pp 2189-2197, issn 1046-6673, 9 p.Article

Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patientsHAUER, Herbert A; BAJEMA, Ingeborg M; VAN HOUWELINGEN, Hans C et al.Kidney international. 2002, Vol 62, Num 5, pp 1732-1742, issn 0085-2538Conference Paper